Wei Jian

Title: Innovator Wei Jian: Pioneering Virus-Like Particle Technology in Biotechnology

Introduction: Wei Jian, an accomplished inventor based in Beijing, China, has made notable contributions to the field of biotechnology. With a focus on viral research and innovative solutions, his work has significant implications for vaccine development and disease prevention.

Latest Patents: Wei Jian holds a patent titled "Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and uses thereof." This patent reveals a groundbreaking engineered fungus capable of efficiently expressing CA10 (Coxsackievirus A10) virus-like particles. The engineered organism utilizes a recombinant vector containing the P1 and 3CD genes of the CA10 virus, optimized for preferred codons. The disclosure also outlines methods for preparing CA10 virus-like particles and vaccines derived from this revolutionary biotechnology.

Career Highlights: Wei Jian is currently affiliated with Beijing Minhai Biotechnology Co., Ltd., where he continues to advance his research in viral engineering and vaccine development. His work at the company stands as a testament to his dedication to exploring new frontiers in biotechnology.

Collaborations: Throughout his career, Wei Jian has collaborated with esteemed colleagues such as Guoshun Li and Meirong Gu. Together, they have contributed to the development of novel biotechnological approaches, emphasizing the importance of teamwork in achieving innovative solutions.

Conclusion: As an inventor, Wei Jian exemplifies the spirit of innovation in biotechnology. His patented work on engineered fungi expressing virus-like particles showcases the potential of his research to impact vaccine formulations and public health initiatives. With ongoing collaborations and dedication to his field, Wei Jian continues to be a valuable asset to the scientific community.